Supplementary Methods
Generation of transgenic mice Two constructs were used to generate the transgenic mice. The full-length WT hGRK4 cDNA was obtained by PCR by using the GRK4 cDNA in pTRE plasmid as the template. The 142V polymorphism was generated using site-directed mutagenesis. The two cDNAs were subcloned into pcDNA3.1. Expression of the cDNA insert was under the control of the cytomegalovirus promoter and bovine growth hormone (BGH) poly (A) signal. Full-length cDNA was verified by sequencing. The GR transgenic mice were generated by microinjecting the cDNA constructs into fertilized eggs obtained from the mating of a (C57BL/6J) F1 female mouse and a (SJL/J) F1 male mouse at the Institute of Animal Laboratory Science, Chinese Academy of Medical Sciences, Comparative Medicine Center, Peking Union Medical College. The presence of the transgene in the transgenic mice was verified by PCR and sequencing studies. The DNA samples were obtained from toes or tails of the hGRK4 WT or hGRK4 142V transgenic mice. The forward primer of hGRK4γ was 5'-GATGAGGACCGAAGTGATTGT-3' and the reverse primer was 5'-TTGCCCAGGTTGTAAATGTG-3' (GenBank accession no. NM_001004057, 560bp). The amplification was performed with the following conditions: 35 cycles of denaturation at 95°C for 2 min, annealing for 30 sec at 58°C, and extension for 40 sec at 72°C. The PCR products were sequenced using the Applied Biosystem 377 DNA sequencer (Perkin Elmer, Wellesley, MA) and compared with the NCBI sequence (NM_001004057).
Arterial sample of AT 1 R knock-out mice AT 1 R knock-out (AT 1 R -/-) mice in this study were obtained from laboratory of Dr Yanfang Chen (Wright State University, Dayton, OH, US). The genotype was determined by PCR analysis of genomic DNA which isolated from mice tail tissue according to previously reported methods 1 . The artery tissues were isolated and washed with ice-cold PBS for several times, and lysed by homogenizer in ice-cold lysis buffer. After centrifugation, the supernatant was mixed in 6×sample buffer and boiled for 5 min, stored at -70 o until use for immunoblotting.
Cell culture
Immortalized RPT cells from WKY 2, 3 were cultured at 37 o C in 95% air and 5% CO 2 atmosphere in FBS% DMEM/F-12 culture media, as previously described. The cells (80% confluence) were extracted in ice-cold lysis buffer, sonicated, kept on ice for 1hr, and centrifuged. The supernatants were used for immunoblotting.
Confocal microscopy of double-stained transfected A10 cells and artery
For the aorta, GRK4 was visualized using the goat anti-GRK4 antibody (1:400) followed by a fluorescein isothiocyanate (FITC); -smooth muscle actin was visualized using rabbit anti-smooth muscle actin antibody (1:50-1:100), followed by a rhodamine (TRITC)-conjugated affinity-purified goat anti-rabbit secondary antibody (red; Molecular Probes).
For the transduced A10 cells, GRK4 (1:100) was visualized using a monoclonal mouse anti-GRK4 receptor antibody (Abcam, Cambridge, UK), followed by AMCA-goat anti-mouse IgG antibody (blue; Jackson ImmunoResearch Laboratory, West Grove, PA). AT 1 R was visualized using a polyclonal rabbit anti-AT 1 R antibody (1:100), followed by rhodamine-conjugated goat anti-rabbit IgG antibody (red; Jackson ImmunoResearch Laboratory, West Grove, PA). Cells that were treated with only AMCA-goat anti-mouse IgG antibody or rhodamine-conjugated goat anti-rabbit IgG antibody revealed no immunofluorescence, and omission of the anti-AT 1 R antibody showed no red or purple color after merging the images (data not shown).
RT-PCR of GRK4 and AT 1 R
For β-actin, the forward primer was 5'-CCACTGCCGCATCCTCTT -3' and the reverse primer was 5'-GTCAGCAATGCCTGGGTA-3' (GenBank accession no. NM_031144, 251bp).
For the AT 1 R, the forward primer was 5'-AAATTGAGTGGCTGTATG-3' and the reverse primer was 5'-CTTGACCTCCCATCTCCT -3' (GenBank accession no. NM_031009, 160bp). The amplifications were both performed with the following conditions: 35 cycles of denaturation at 94°C for 2 min, annealing for 30 sec at 59°C, and extension for 45 sec at 72°C. For GRK4, the forward primer was 5'-TGTCCTGATCCTGAGGC -3' and the reverse primer was 5'-ACACACCCTGTCGCAAAT -3' (GenBank accession no. NM_022928.1, 125bp). The amplification was performed with the following conditions: 35 cycles of denaturation at 95°C for 2 min, annealing for 30 sec at 59°C, and extension for 45 sec at 72°C. 
Intracellular calcium measurement

Aorta ring study
Aorta rings were mounted between a post-and a force-transducer (AD Instruments, Sydney, Australia) that was attached to a micrometer, then immersed into a 10 ml isolated organ chamber (Scientific Instruments, Barcelona, Spain) containing Krebs-Henseleit solution (K-H solution; in mM): 118 NaCl, 4.7 KCl, 25 NaHCO 3 , 1.03 KH2PO4, 0.45 MgSO4•7H2O, 2.5 CaCl2, and 11.1 glucose at pH 7.35 to 7.45, which was continuously bubbled with 95% O2/5% CO2 gas mixture, and the temperature was maintained at 37 . Preload tension was 0.5g, and the K ℃ -H solution was replaced every 20 min. After a 2-hr equilibration, Ang II (final concentrations, 10-8-10-5M) was added into the organ chamber with or without a 15 min-candesartan (10-6M) pre-incubation. The tension of the aorta rings was recorded and expressed by change in amplitude from baseline. Figure S8 . Effect of Ang II and the AT 1 R antagonist, candesartan, on systolic blood pressure (BP) in hGRK4 γ WT and hGRK4 γ 142V transgenic mice. Ang II (1 mg/kg/min at the rate of 10 μl/hr) increased systolic BP to a greater extent in hGRK4 γ A142V than hGRK4 γ WT transgenic mice. Conversely, an intravenous administration of candesartan (0.139 mg/kg/min at the rate of 10 μl/hr) by mini-pump decreased systolic BP to a greater extent in hGRK4 γ 142V than hGRK4 γ WT transgenic mice. The mice were anesthetized with pentobarbital and BPs measured from the femoral artery. BPs were obtained after a 1-hr stabilization period (n =11, *P<0.001 vs. WT mice).
